- Home
- KMI vs CGC Comparison
KMI vs CGC Comparison
Compare KMI & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KMI | CGC |
|---|---|---|
| Founded | 1936 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Pharmaceuticals and Biotechnology |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.1B | 467.3M |
| IPO Year | 2010 | 2023 |
Fundamental Metrics
Financial Performance| Metric | KMI | CGC |
|---|---|---|
| Price | $30.93 | $1.06 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 1 |
| Target Price | ★ $33.69 | N/A |
| AVG Volume (30 Days) | ★ 9.7M | 3.7M |
| Earning Date | 04-22-2026 | 05-29-2026 |
| Dividend Yield | ★ 3.74% | N/A |
| EPS Growth | 17.09 | ★ 84.17 |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $16,937,000,000.00 | $12,759,000.00 |
| Revenue This Year | $5.43 | $8.27 |
| Revenue Next Year | $4.52 | $15.68 |
| P/E Ratio | $37.78 | ★ N/A |
| Revenue Growth | ★ 12.17 | N/A |
| 52 Week Low | $25.60 | $0.84 |
| 52 Week High | $34.81 | $2.38 |
Technical Indicators
Market Signals| Indicator | KMI | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 41.62 | 65.75 |
| Support Level | $30.92 | $1.01 |
| Resistance Level | $33.02 | $1.08 |
| Average True Range (ATR) | 0.70 | 0.04 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 16.67 | 90.91 |
Price Performance
Historical ComparisonAbout KMI Kinder Morgan Inc.
Kinder Morgan operates natural gas, crude oil, and refined products pipelines connecting producing regions to demand centers. It is principally involved in the gathering, storage, and transmission of natural gas across the continental United States. It also operates distribution centers for refined products along with the largest fleet of Jones Act-compliant tankers.
About CGC Canopy Growth Corporation
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.